Join us on September 21st for an ActiGraph webinar.
Operationalizing Digital Health Technologies: Successes and Failures in Clinical Research

Evaluating Usability and Incorporating the Patient Experience in DECODE-Nocturnal Scratch

The Digital Endpoint Collaboration to accelerate Outcome DEvelopment (DECODE) Nocturnal Scratch...

Developing a Patient-Centric Measure of Nocturnal Scratch: A Q&A with DiMe

The adoption of wearable Digital Health Technologies (DHTs) to measure outcomes of interest in...

Perspective on the FDA's Final Digital Health Technologies Guidance

Regulatory guidance plays a pivotal role in shaping the ecosystem of clinical research and...

ActiTrack Adherence Monitoring: Maximize the Value of Wearable Data

In the evolving landscape of clinical trials, wearable digital health technologies give clinical...

Frequently Asked Questions: ActiGraph LEAP

The ActiGraph LEAP™next generation multisensor wearable device is now available for use in academic...

Researching New Digital Measures in Heart Disease | DEAR Grant Profile

Cardiovascular diseases, according to the World Health Organization, are the leading cause of death...

The Vital Role of Clinical Research Sites in DHT Deployment

Once your team has made the decision to collect digital measures in your clinical trial and...

Frequently Asked Questions: ActiGraph GT9X Link

As of August 23, 2023, ActiGraph discontinued the sale of new GT9X Link wearable digital health...

ActiGraph No Longer Selling New GT9X Link Wearable Devices

Effective August 23, 2023, new GT9X Link wearable devices will no longer be available for purchase....

5 Important Questions to Ask Your Wearable Technology Partner

Wearable, sensor-based digital health technologies (DHTs) can provide clinical researchers with...

Why Prioritizing Patients Changes How Study Teams Approach DHTs

Although technology provides vast opportunities to improve clinical trial efficiency and unlock new...

Validating Wearable Technology for ALS Research | DEAR Grant Profile

The development of new drugs for rare diseases is hampered by the lack of precise and reliable...